KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Revenue (2016 - 2025)

Historic Revenue for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $12.2 billion.

  • Bristol Myers Squibb's Revenue rose 277.5% to $12.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $48.0 billion, marking a year-over-year increase of 126.28%. This contributed to the annual value of $48.3 billion for FY2024, which is 731.9% up from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Revenue is $12.2 billion, which was up 277.5% from $12.3 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Revenue ranged from a high of $12.3 billion in Q4 2024 and a low of $11.0 billion during Q3 2023
  • In the last 5 years, Bristol Myers Squibb's Revenue had a median value of $11.6 billion in 2022 and averaged $11.7 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Revenue skyrocketed by 1553.95% in 2021 and then crashed by 559.63% in 2025.
  • Bristol Myers Squibb's Revenue (Quarter) stood at $12.0 billion in 2021, then dropped by 4.83% to $11.4 billion in 2022, then increased by 0.62% to $11.5 billion in 2023, then increased by 7.54% to $12.3 billion in 2024, then dropped by 0.97% to $12.2 billion in 2025.
  • Its last three reported values are $12.2 billion in Q3 2025, $12.3 billion for Q2 2025, and $11.2 billion during Q1 2025.